Europe Veterinary Healthcare Market was worth $9.75 billion in 2020 and estimated to be growing at a CAGR of 6.4%, to reach $13.3 billion by 2025.
Veterinary healthcare market covers both wild and pet animals and the market associated with diagnosis, treatment, and prevention of their ailments. Increasing awareness of livestock health and pet animals’ numbers are the key factors influencing this market.
Drivers and Restraints
Very few requirements for animal health drugs approval combined with the growth in companion animal numbers are the major factors driving the market for Veterinary healthcare. Also, awareness is rising incidences of zoonotic diseases is also a driving force for the market. However, increasing regulation on antibiotics is expected to remain a major restraint for the market. Apart from that increasing costs regulation related to animal testing is also a major hurdle for the growth of animal healthcare market.
This research report segmented and sub-segmented into the following categories:
Europe has the dominating share in the global wide market and tend to remain so in the forecast period.
Key Developments in the Market
Key players operating in the Europe Veterinary Healthcare Market profiled in this report are:
Companies like,
Reasons to Purchase Europe Veterinary Healthcare Market Report
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Pharmaceuticals
5.1.1.1 Vaccines
5.1.1.2 Antibiotics
5.1.1.3 Parasiticides
5.1.1.4 Others
5.1.2 Feed Additives
5.1.2.1 Medical Feed Additives
5.1.2.2 Nutritional Feed Additives
5.1.3 Y-o-Y Growth Analysis, By Product
5.1.4 Market Attractiveness Analysis, By Product
5.1.5 Market Share Analysis, By Product
5.2 Animal Type
5.2.1 Livestock Animals
5.2.1.1 Cattle
5.2.1.2 Swine
5.2.1.3 Sheep
5.2.1.4 Poultry
5.2.1.5 Aquatic
5.2.1.6 Others
5.2.2 Companion Animals
5.2.2.1 Dogs
5.2.2.2 Cats
5.2.3 Y-o-Y Growth Analysis, By Animal Type
5.2.4 Market Attractiveness Analysis, By Animal Type
5.2.5 Market Share Analysis, By Animal Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Animal Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Animal Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Animal Type
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 MSD Animal Health
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bayer AG
8.3 Boehringer Ingelheim GmbH
8.4 Ceva Santé Animale
8.5 Eli Lilly and Company
8.6 Cargill, Inc
8.7 Novasep
8.8 Koninklijke DSM N.V
8.9 Nutreco N.V.
8.10 SeQuent Scientific Ltd.
8.11 Virbac S.A.
8.12 Vétoquinol S.A.
8.13 Zoetis Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
